Cancer (Oncology)

Xpreza 200® Azacitidine Tablets
Azacitidine 200mg
- Composition
- Azacitidine 200mg
- Dosage form
- Tablet
- Pack size
- Bottle of 14 Tablet
- Manufacturer
- Natco
- Also known as
- Onureg
Supplied against a valid prescription where required, in line with the regulations of the destination country.
Xpreza 200 mg contains azacitidine and is listed for the treatment of adult patients with myelodysplastic syndromes (MDS). Azacitidine acts on abnormal blood-forming cells and helps manage disorders affecting normal blood cell production.
As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.
Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.
Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.
Store below 30 °C in a dry place, in the original pack, out of reach of children.
Need product documents?
Ask for the pack insert, batch details or a COA with your quote.
Ask on WhatsApp →Related products
Cancer (Oncology)
Cancer (Oncology)
Cancer (Oncology)
Cancer (Oncology)
